3Nagasue N, Kohno H, Chang YC, et al. Liver resection for hepatocellular carcinoma[J]. Ann Surg, 1993,2 : 17
4Zuppa AF, Helfaer MA, Adamson PC. Propofol pharmacokinetics[J]. Pediatr Crit Care Med, 2003,4(1) : 124-- 125
5Malnga S, Leeman J. The Blood/ gas Solubilitis of Sevoflurane, Isoflurane, Halothane and Serum Construent Concentrations in Neonates and Abluts[J]. Anesthesiology, 1990, 72:793
6Kharasch ED, Frink EJ, Artru A, et al. Long--duration low -- flow sevoflurane and isoflurane effects on postoperative renal and hepatic function[J]. Anesth Analg, 2001,93: 1 511 -- 1 520
7Catania JM, Parrish AR, Gandolfi AJ. Toxicity of a sevoflurane degradation product incubated with rat liver and renal cortical slices[J]. Drug Chem Toxicol, 2001,24: 347-- 357
8George D, Michael J, Robert L, et al. Factors associated with successful tracheal intubation of children with sevoflurane and no muscle relaxant. Anesth Analg, 2002, 95(3): 615-620.
9O' Shea h, Mouhrie S, Drummond GB. Influence of nitrous oxide on induction of anaesthesia with sevoflurane. Br J Anaesth, 2001, 87 (2) : 286-288.
10Kihara S, Yaguchi Y, Inomata S, et al. Influence of nitrous oxide on minimum alveolar concentration of sevoflurane for laryngeal mask insertion in children. Anesthesiology, 2003, 99(5): 1055-1058.
